Oligometastatic NSCLC: Current Perspectives and Future Challenges by Sara Torresan, Jacopo Costa, Carol Zanchetta, Lorenzo De Marchi, Simona Rizzato, Francesco Cortiula

Subjects: “…NSCLC…”
Get full text

Early local therapy in combination with PD-1/PD-L1 inhibitors in oligometastatic non-small cell lung cancer: results from a prospective multicenter observational study by Jie Gao, Aihua Lan, Xi Yang, Li Chu, Xiao Chu, Yue Zhou, Hongru Chen, Silai Yu, Yechun Pang, Jie Hu, Qian Chu, Jianjiao Ni, Zhengfei Zhu

Subjects: Get full text

Symptomatic Bradycardia Due to Alectinib in a Patient with Advanced Stage of NSCLC by Ceva Wicaksono Pitoyo, Cleopas Martin Rumende, Anindita Kartika Wiraputri, Fatira Ratri Audita

Subjects: Get full text

A Phase 1/1B Trial of Pembrolizumab and Trametinib in Advanced NSCLC Enriched for KRAS Mutations by Jonathan W. Riess, MD, MS, Matthew S. Lara, BS, Guillaume Luxardi, PhD, Miguel Lopez de Rodas, MD, Michiko Shimoda, PhD, Karen Kelly, MD, Primo N. Lara, MD, Laurel Beckett, PhD, Arta Monjazeb, MD, PhD, Kurt A. Schalper, MD, PhD, Emanual Maverakis, MD, David R. Gandara, MD

Subjects: “…NSCLC…”
Get full text

Identifying key genes associated with recurrence in non-small cell lung cancer through TCGA and single-cell analysis by Weiyuan Li, Duo Han, Chunxiao Cao, Yuning Xie, Jingxia Shen

Subjects: “…NSCLC…”
Get full text

Single‐center study to determine the safety and efficacy of CT‐707 in Chinese patients with advanced anaplastic lymphoma kinase‐rearranged non‐small‐cell lung cancer by Peng Song, Xiaotong Zhang, Dongliang Yang, Hanping Wang, Xiaoyan Si, Li Zhang

Subjects: Get full text

Berbamine as potential STING inhibitor For KRAS-mutant non-small cell lung cancer by Haoxin Yan, Jumin Huang, Yuwei Wang, Yizhong Zhang, Wenkang Ren, Zhiran Zhai, Yuping Tang, Huanling Lai, Xingxing Fan, Lihua Liu, Elaine Lai-Han Leung

Subjects: “…NSCLC…”
Get full text

Spatial heterogeneity of T cell repertoire across NSCLC tumors, tumor edges, adjacent and distant lung tissues by Qikang Hu, Meredith L. Frank, Yang Gao, Liyan Ji, Muyun Peng, Chen Chen, Bin Wang, Yan Hu, Zeyu Wu, Jina Li, Lu Shu, Qiongzhi He, Yingqian Zhang, Xuefeng Xia, Jianjun Zhang, Xin Yi, Alexandre Reuben, Fenglei Yu

Subjects: Get full text

A Real‐World Study: Therapeutic Outcomes of ROS1‐Positive Advanced NSCLC by Hanqi Yuan, Zihua Zou, Xuezhi Hao, Yan Li, Junling Li, Jianming Ying, Puyuan Xing

Subjects: Get full text

Perioperative Chemo/Immunotherapies in Lung Cancer: A Critical Review on the Value of Perioperative Sequences by Thoma’ Dario Clementi, Francesca Colonese, Stefania Canova, Maria Ida Abbate, Luca Sala, Francesco Petrella, Gabriele Giuseppe Pagliari, Diego Luigi Cortinovis

Subjects: “…resectable/early-stage NSCLC…”
Get full text

Impact of Intraoperative Dexamethasone on Postoperative Complications and Long-Term Survival in Patients with Non-Small Cell Lung Cancer: A retrospective Propensity Score-Matched S... by Zhu W, Zhu L, Wang X, Tan H

Subjects: Get full text

Molecular profile of non-small cell lung cancer in a predominantly Black African population in Kenya: A single institution review by Sitna Mwanzi, Shahin Sayed, Swati Das, Jonathan Wawire, Priscilla Njenga, Jasmit Shah, Asim Jamal Shaikh

Subjects: “…NSCLC…”
Get full text

A Meta‐Analysis of Efficacy and Safety of Neoadjuvant Immunotherapy Plus Chemotherapy for Resectable Non‐Small Cell Lung Cancer by Xinru Sun, Tianhua Kang, Baodong Liu, Yin Zhang, Guangming Huang

Subjects: Get full text

Phase 2 Trial of Combination Radiotherapy and Pembrolizumab Plus Chemotherapy in Patients With Previously Untreated Metastatic NSCLC: NJLCG 1902 by Yoko Tsukita, MD, PhD, Rei Umezawa, MD, PhD, Taku Nakagawa, MD, PhD, Akira Anbai, MD, PhD, Tomonori Makiguchi, MD, PhD, Hisashi Tanaka, MD, PhD, Yosuke Horii, MD, PhD, Aya Suzuki, MD, Ryo Morita, MD, PhD, Hitomi Nogawa, MD, Hiroshi Yokouchi, MD, PhD, Nozomu Kimura, MD, PhD, Keiichi Jingu, MD, PhD, Akira Inoue, MD, PhD, Hisatoshi Sugiura, MD, PhD, Eisaku Miyauchi, MD, PhD

Subjects: “…NSCLC…”
Get full text

pTNM System in Non Small Cell Lung Carcinoma by Heriawaty Hidajat, Sutjahjo Endarjo, Ruth E Sembiring, Aziza Icksan, Elisna Syahrudin, Agung Wibawanto

Subjects: Get full text

The Effects of Silibinin Combined With EGFR‐TKIs in the Treatment of NSCLC by Xiaocen Wang

Subjects: Get full text

Occult Node Detection With Lobectomy Versus Segmentectomy for Stage IA NSCLC by Yota Suzuki, MD, Rajeev Dhupar, MD, Inderpal S. Sarkaria, MD, MBA, Ian G. Christie, MD, Summer N. Mazur, BS, Arjun Pennathur, MD, James D. Luketich, MD, Ryan M. Levy, MD, Rodney J. Landreneau, MD, Matthew J. Schuchert, MD

Subjects: “…NSCLC…”
Get full text

STUDI IN SILICO KOMPLEKS LIGAND-RESEPTOR EUGENOL DAUN BASIL (Ocimum basilicum L.) DENGAN RESEPTOR HER2 PADA NON-SMALL CELL LUNG CANCER (NSCLC) DENGAN KONTROL GEFITINIB by Martina Kurnia Rohmah

Subjects: Get full text

Concomitant Use of Analgesics and EGFR TKIs in Lung Cancer Patients: Outcomes and Perspectives From a Finnish Retrospective Register–Based Study by Laura S. Puuniemi, Sanna M. E. Iivanainen, Martti Arffman, Riitta L. Kaarteenaho, Jussi P. Koivunen

Subjects: Get full text

Radiation-Induced Tumor-Derived Extracellular Vesicles Combined with Tyrosine Kinase Inhibitors: An Effective and Safe Therapeutic Approach for Lung Adenocarcinoma with EGFR19Del by Yao Li, Yaping Long, Xiangwei Ge, Pengfei Zhang, Tao Li, Liangliang Wu, Hao Fan, Zhijuan Du, Qiaowei Liu, Yi Hu

Subjects: Get full text